Skip to Content


In the US, Vigamox (moxifloxacin ophthalmic) is a member of the drug class ophthalmic anti-infectives and is used to treat Conjunctivitis - Bacterial and Ophthalmic Surgery.

US matches:

Ingredient matches for Vigamox


Moxifloxacin is reported as an ingredient of Vigamox in the following countries:

  • Bosnia & Herzegowina
  • Czech Republic
  • Ecuador
  • Georgia
  • Peru
  • Slovakia
  • Turkey

Moxifloxacin hydrochloride (a derivative of Moxifloxacin) is reported as an ingredient of Vigamox in the following countries:

  • Argentina
  • Bulgaria
  • Canada
  • Chile
  • Colombia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Israel
  • Italy
  • Latvia
  • Lithuania
  • Malaysia
  • Malta
  • Netherlands
  • Oman
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Singapore
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Tanzania
  • Thailand
  • United States
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.